|
|
Article: Needles may not be the future of immunotherapy.(Clinical Rounds)
- Article from:
- Skin & Allergy News
- Article date:
- June 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
San Antonio -- Adults with dustmite allergy respond better to sublingual immunotherapy than they do to standard allergy medications, according to the results of a study conducted by Italian researchers.
"The clinical efficacy of sublingual immunotherapy has been previously established in pollen, but not dust-mite allergy," said lead author Carlo Lombardi, M.D., who presented his research at the annual meeting of the American Academy of Allergy, Asthma, and Immunology.
Although the effect of sublingual immunotherapy is relatively easy to assess in pollen allergy, an ailment that has a fixed, seasonal occurrence, its effect on year-round dust-mite allergy ...